GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ouro Fino Saude Animal Participacoes SA (BSP:OFSA3) » Definitions » Cash Ratio

Ouro Finoude Animal Participacoes (BSP:OFSA3) Cash Ratio : 1.31 (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Ouro Finoude Animal Participacoes Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Ouro Finoude Animal Participacoes's Cash Ratio for the quarter that ended in Dec. 2023 was 1.31.

Ouro Finoude Animal Participacoes has a Cash Ratio of 1.31. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.

The historical rank and industry rank for Ouro Finoude Animal Participacoes's Cash Ratio or its related term are showing as below:

BSP:OFSA3' s Cash Ratio Range Over the Past 10 Years
Min: 0.16   Med: 0.47   Max: 1.31
Current: 1.31

During the past 10 years, Ouro Finoude Animal Participacoes's highest Cash Ratio was 1.31. The lowest was 0.16. And the median was 0.47.

BSP:OFSA3's Cash Ratio is ranked better than
69.46% of 1028 companies
in the Drug Manufacturers industry
Industry Median: 0.57 vs BSP:OFSA3: 1.31

Ouro Finoude Animal Participacoes Cash Ratio Historical Data

The historical data trend for Ouro Finoude Animal Participacoes's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ouro Finoude Animal Participacoes Cash Ratio Chart

Ouro Finoude Animal Participacoes Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.21 1.02 0.66 0.64 1.31

Ouro Finoude Animal Participacoes Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.64 1.00 0.86 0.84 1.31

Competitive Comparison of Ouro Finoude Animal Participacoes's Cash Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Ouro Finoude Animal Participacoes's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ouro Finoude Animal Participacoes's Cash Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ouro Finoude Animal Participacoes's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Ouro Finoude Animal Participacoes's Cash Ratio falls into.



Ouro Finoude Animal Participacoes Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Ouro Finoude Animal Participacoes's Cash Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash Ratio (A: Dec. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=304.029/232.656
=1.31

Ouro Finoude Animal Participacoes's Cash Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash Ratio (Q: Dec. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=304.029/232.656
=1.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ouro Finoude Animal Participacoes  (BSP:OFSA3) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Ouro Finoude Animal Participacoes Cash Ratio Related Terms

Thank you for viewing the detailed overview of Ouro Finoude Animal Participacoes's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Ouro Finoude Animal Participacoes (BSP:OFSA3) Business Description

Traded in Other Exchanges
N/A
Address
Anhanguera Highway SP 330, Km 298, Industrial District, Cravinhos, SP, BRA, 14140-000
Ouro Fino Saude Animal Participacoes SA is engaged in the production and sale of veterinary drugs, vaccines, and other products for cattle, pigs, poultry, sheep, horses and goats and pets. The company reportable segments are Production animals, Companion animals, and International operations. It generates maximum revenue from the Production animals segment. The product portfolio includes Anticoccidials, Antimicrobials, Biological, Ectoparasiticides, Endectocides, Fortifiers / Supplements, and others.

Ouro Finoude Animal Participacoes (BSP:OFSA3) Headlines

No Headlines